Top

Published in:

Open Access 01-03-2019 | Original Article

The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin–ramipril study

Authors: Andreas Jekell, Majid Kalani, Thomas Kahan

Published in: Heart and Vessels | Issue 3/2019

Abstract

There are several non-invasive methods to study endothelial function, but their interrelation and association to cardiovascular risk have not been well evaluated. We studied macrovascular and microvascular endothelial function simultaneously in different vascular beds in relation to cardiovascular mortality risk (Systematic Coronary Risk Evaluation, SCORE) and hypertension induced cardiac organ damage, and their interrelationship. The study investigated 71 hypertensive patients by forearm post-ischemic flow-mediated vasodilation, pulse wave analysis (applanation tonometry) and beta 2-adrenoceptor agonist stimulation for changes in reflection index, skin microvascular reactivity by laser Doppler fluxmetry with iontophoresis and heat-induced hyperaemia, and coronary microvascular function by subendocardial viability ratio (derived from pulse wave analysis). Flow mediated vasodilation related inversely to SCORE (r = 0.34, P = 0.011). Adding microalbuminuria and pulse wave velocity strengthened the associations. Pulse wave reflection changes did not relate to SCORE. Skin microvascular reactivity related inversely to SCORE (peak flux change to sodium nitroprusside r = 0.29, P = 0.033, and to heating r = 0.31, P = 0.018). Subendocardial viability ratio did not relate to SCORE. Endothelial function indices showed no consistent relation to cardiac target organ damage. The agreement between the different methods for evaluating indices of macrovascular and microvascular endothelial function was weak. In conclusion, indices of macrovascular and microvascular endothelial function relate to cardiovascular mortality risk. Their use may improve cardiovascular risk prediction in hypertension. However, methods representing different vascular beds show little interrelationship and are not interchangeable, which may depend on different pathogenetic mechanisms representing different aspects of future cardiovascular risk.

Trial registry: NCT02901977

Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G (2001) Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104:191–196CrossRefPubMed

Lind L, Fors N, Hall J, Marttala K, Stenborg A (2005) A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol 25:2368–2375CrossRefPubMed

Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235–1241CrossRefPubMed

Campuzano R, Moya JL, García-Lledó A, Tomas JP, Ruiz S, Megías A, Balaguer J, Asín E (2006) Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis. J Hypertens 24:1581–1588CrossRefPubMed

Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM (2009) Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120:502–509CrossRefPubMedPubMedCentral

Muiesan ML, Salvetti M, Paini A, Monteduro C, Galbassini G, Poisa P, Porteri E, Agabiti-Rosei C, Paderno V, Belotti E, Rizzoni D, Castellano M, Agabiti-Rosei E (2008) Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens 26:1612–1618CrossRefPubMed

Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA (2003) Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41:1769–1775CrossRefPubMed

Frick M, Suessenbacher A, Alber HF, Dichtl W, Ulmer H, Pachinger O, Weidinger F (2005) Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol 46:1006–1010CrossRefPubMed

Lind L, Berglund L, Larsson A, Sundström J (2011) Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 123:1545–1551CrossRefPubMed

10.

Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft JR (2002) Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22:147–152CrossRefPubMed

11.

Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, Ritter JM, Anggård EE (1999) Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 34:2007–2014CrossRefPubMed

12.

Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C (2004) Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis 173:97–102CrossRefPubMed

13.

Östlund Papadogeorgos N, Jörneskog G, Bengtsson M, Kahan T, Kalani M (2016) Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome. Cardiovasc Diabetol 15:66. https://doi.org/10.1186/s12933-016-0385-6 CrossRefPubMedPubMedCentral

14.

Serne EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD (2001) Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 38:238–242CrossRefPubMed

15.

Ijzerman RG, de Jongh RT, Beijk MA, van Weissenbruch MM, Delemarre-van de Waal HA, Serné EH, Stehouwer CD (2003) Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 33:536–542CrossRefPubMed

16.

Jörneskog G, Kalani M, Kuhl J, Båvenholm P, Katz A, Allerstrand G, Alvarsson M, Efendic S, Östenson CG, Pernow J, Wahren J, Brismar K (2005) Early microvascular dysfunction in healthy normal-weight males with heredity for type 2 diabetes. Diabetes Care 28:1495–1497CrossRefPubMed

17.

Hoffman JI, Buckberg GD (1978) The myocardial supply:demand ratio–a critical review. Am J Cardiol 41:327–332CrossRefPubMed

18.

Tsiachris D, Tsioufis C, Syrseloudis D, Roussos D, Tatsis I, Dimitriadis K, Toutouzas K, Tsiamis E, Stefanadis C (2012) Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens 26:64–70CrossRefPubMed

19.

Theilade S, Hansen TW, Rossing P (2014) Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes. Am J Hypertens 27:1152–1159CrossRefPubMed

20.

Di Micco L, Salvi P, Bellasi A, Sirico ML, Di Iorio B (2013) Subendocardial viability ratio predicts cardiovascular mortality in chronic kidney disease patients. Blood Purif 36:26–28CrossRefPubMed

21.

Krumholz HM, Larson M, Levy D (1995) Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 25:879–884CrossRefPubMed

22.

de Simone G, Izzo R, Aurigemma GP, De Marco M, Rozza F, Trimarco V, Stabile E, De Luca N, Trimarco B (2015) Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities. J Hypertens 33:745–754CrossRefPubMed

23.

Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003CrossRefPubMed

24.

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743–753CrossRefPubMed

25.

Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim SP (2003) Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327:1267CrossRefPubMedPubMedCentral

26.

Ghitescu L, Robert M (2002) Diversity in unity: the biochemical composition of the endothelial cell surface varies between the vascular beds. Microsc Res Tech 57:381–389CrossRefPubMed

27.

Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lüscher TF, Shechter M, Taddei S, Vita JA, Lerman A (2012) The assessment of endothelial function: from research into clinical practice. Circulation 126:753–767CrossRefPubMedPubMedCentral

28.

Hellmann M, Roustit M, Cracowski JL (2015) Pharmacol Rep 67:803–810CrossRefPubMed

29.

Jekell A, Kalani M, Kahan T (2017) The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study. Heart Vessels 32:674–684CrossRefPubMed

30.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral

31.

HeartScore. Available from https://heartscore.escardio.org/2012/calc.aspx?model=europelow. Accessed 1 July 2017.

32.

Iacobaeus C, Kahan T, Jörneskog G, Bremme K, Thorsell M, Andolf E (2016) Fetal growth is associated with first-trimester maternal vascular function. Ultrasound Obstet Gynecol 48:483–490CrossRefPubMed

33.

Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618CrossRefPubMed

34.

Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, Gottdiener J, Haluska B, Ofili E, Segers P, Senior R, Tapp RJ, Zamorano JL (2015) Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr 28:727–754CrossRefPubMed

35.

Safar ME, Struijker-Boudier HA (2010) Cross-talk between macro- and microcirculation. Acta Physiol (Oxf) 198:417–430CrossRef

36.

Fortier C, Mac-Way F, Desmeules S, Marquis K, De Serres SA, Lebel M, Boutouyrie P, Agharazii M (2015) Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension 65:378–384CrossRefPubMed

37.

Millgård J, Hägg A, Sarabi M, Lind L (2002) Endothelium-dependent vasodilation in normotensive subjects with a familial history of essential hypertension and in young subjects with borderline hypertension. Blood Press 11:279–284CrossRefPubMed

38.

Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt P, Olsen MH (2010) Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 31:883–891CrossRefPubMed

39.

Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Olsen MH (2012) Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts. J Hypertens 30:1928–1936CrossRefPubMed

40.

Ekholm M, Jekell A, Wallén NH, Gigante B, Kahan T (2018) The effects of angiotensin converting enzyme inhibition and alpha 1-adrenoceptor blockade on inflammation and haemostasis in human hypertension. J Cardiovasc Pharmacol. 71:240–247PubMed

41.

Gori T, Di Stolfo G, Sicuro S, Dragoni S, Lisi M, Parker JD, Forconi S (2006) Correlation analysis between different parameters of conduit artery and microvascular vasodilation. Clin Hemorheol Microcirc. 35:509–515PubMed

42.

Meyer MF, Lieps D, Schatz H, Pfohl M (2008) Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction. Microvasc Res. 76:61–65CrossRefPubMed

43.

Sandoo A, Carroll D, Metsios GS, Kitas GD, Veldhuijzen van Zanten JJ (2011) The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 13:R99CrossRefPubMedPubMedCentral

44.

Debbabi H, Bonnin P, Ducluzeau PH, Lefthériotis G, Levy BI (2010) Noninvasive assessment of endothelial function in the skin microcirculation. Am J Hypertens. 23:541–546CrossRefPubMed

45.

Hansell J, Henareh L, Agewall S, Norman M (2004) Non-invasive assessment of endothelial function—relation between vasodilatory responses in skin microcirculation and brachial artery. Clin Physiol Funct Imaging. 24:317–322CrossRefPubMed

46.

Rambaran C, Jiang B, Ritter JM, Shah A, Kalra L, Chowienczyk PJ (2008) Assessment of endothelial function: comparison of the pulse wave response to beta 2-adrenoceptor stimulation with flow mediated dilatation. Br J Clin Pharmacol. 65:238–243CrossRefPubMed

47.

Ibrahim NNIN, Rasool AHG (2017) Assessment of macrovascular endothelial function using pulse wave analysis and its association with microvascular reactivity in healthy subjects. Skin Res Technol. 23:321–325CrossRefPubMed

48.

Hill CE, Phillips JK, Sandow SL (2001) Heterogeneous control of blood flow amongst different vascular beds. Med Res Rev. 21:1–60CrossRefPubMed

49.

Konukoglu D, Uzun H (2017) Endothelial dysfunction and hypertension. Adv Exp Med Biol. 956:511–540CrossRefPubMed

50.

Holowatz LA, Thompson CS, Minson CT, Kenney WL (2005) Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol 563:965–973CrossRefPubMedPubMedCentral

51.

Dimitroulas T, Sandoo A, Hodson J, Smith JP, Kitas GD (2016) In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort. Scand J Clin Lab Invest. 76:331–337CrossRefPubMed

52.

Bøttcher M, Madsen MM, Refsgaard J, Buus NH, Dørup I, Nielsen TT, Sørensen K (2001) Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve. Circulation 103:1109–1114CrossRefPubMed

53.

Sütsch G, Hess OM, Franzeck UK, Dörffler T, Bollinger A, Krayenbühl HP (1992) Cutaneous and coronary flow reserve in patients with microvascular angina. J Am Coll Cardiol. 20:78–84CrossRefPubMed

54.

Ras RT, Streppel MT, Draijer R, Zock PL (2013) Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol 168:344–351CrossRefPubMed

55.

McEniery CM, Wallace S, Mackenzie IS, McDonnell B, DE Yasmin Newby, Cockcroft JR, Wilkinson IB (2006) Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 48:602–608CrossRefPubMed

56.

Sandoo A, Protogerou AD, Hodson J, Smith JP, Zampeli E, Sfikakis PP, Kitas GD (2012) The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. Arthritis Res Ther 14:R258CrossRefPubMedPubMedCentral

57.

Laugesen E, Høyem P, Fleischer J, Kumarathas I, Knudsen ST, Hansen KW, Christiansen JS, Hansen TK, Poulsen PL (2016) Reduced subendocardial viability ratio is associated with unfavorable cardiovascular risk profile in women with short duration of type 2 diabetes. Am J Hypertens 29:1165–1172CrossRefPubMed

58.

Agarwal SC, Allen J, Murray A, Purcell IF (2012) Laser Doppler assessment of dermal circulatory changes in people with coronary artery disease. Microvasc Res 84:55–59CrossRefPubMed

59.

Olsen MH, Wachtell K, Hermann KL, Bella JN, Dige-Petersen H, Rokkedal J, Ibsen H (2002) Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudy. Blood Press 11:285–292CrossRefPubMed

60.

Lind L (2008) Left ventricular mass is related to endothelium-dependent vasodilation in the forearm, but not in the brachial artery, in elderly subjects: the Prospective Investigation of the Vasculature in Uppsala Seniors study. J Hum Hypertens 22:767–773CrossRefPubMed

61.

Nigam A, Mitchell GF, Lambert J, Tardif JC (2003) Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol 92:395–399CrossRefPubMed

Title: The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin–ramipril study
Authors: Andreas Jekell
Majid Kalani
Thomas Kahan
Publication date: 01-03-2019
Publisher: Springer Japan
Published in: Heart and Vessels / Issue 3/2019
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-018-1265-7

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin–ramipril study

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2019

Catheter ablation of paroxysmal atrial fibrillation in patients with sick sinus syndrome

Echocardiographic surrogates of right atrial pressure in pulmonary hypertension

Plaque erosion versus rupture characterization by optical frequency domain imaging before and after coronary stenting following successful fibrinolysis for ST-segment elevation myocardial infarction

Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR

Endothelial damage and thromboembolic risk after pulmonary vein isolation using the latest ablation technologies: a comparison of the second-generation cryoballoon vs. contact force-sensing radiofrequency ablation

Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page